Monday, December 23, 2024
HomeTagsC2i Genomics

C2i Genomics

Veracyte Completes Acquisition of C2i Genomics

Veracyte, Inc., a leading cancer diagnostics company, announced it has completed its acquisition of C2i Genomics, Inc., adding whole-genome minimal residual disease (MRD) capabilities...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics